Skip to main content
. 2024 Jan 20;24(2):662. doi: 10.3390/s24020662

Table 3.

Demographic and clinical characteristics of participants.

PwPD (n = 22) HS (n = 10) p-Value
Age [years] 72.5 (63; 79.9) 70.5 (65.5; 76.1) 0.51
Sex [female/male] 8/14 6/4 0.21
Body Mass Index (BMI) [kg/m2] 24.7 (19.2; 31.6) 24.3 (20.9; 27.6) 0.73
mH&Y stage 2 (1.5; 2.5) - -
MDS-UPDRS II 6 (1.1; 19) - -
MDS-UPDRS III 31 (13.2; 42.9) - -
6MWT [m] 488 (262.2; 578.8) 565.8 (487.4; 616.7) 0.02 *
TUG [s] 9.5 (6.7; 16.8) 7.8 (6.7; 11.8) 0.16
PIGD 0.5 (0; 1) - -
Akinesia/Bradykinesia 19 (5.3; 29.9) - -
Most/least affected side (right/left) 10/12 - -
Leg Asymmetry Index 0.3 (0.1; 0.9) - -
Rigidity index 3 (1; 7.9) - -
Tremor index 0.2 (0; 0.8) - -
MoCA 24 (20; 28) - -
Adjusted MoCA score 23.0 (19.6; 27.5) - -

Values are median (5th percentile; 95th percentile) or numbers. * indicates a p-value lower than 0.05. PwPD: People with Parkinson’s Disease; HS: Healthy Subjects; mH&Y: modified Hoehn and Yahr; MDS-UPDRS: Movement Disorder Society—Unified Parkinson’s Disease Rating Scale; 6MWT: 6-Minute Walk Test; TUG: Timed Up and Go; PIGD: Postural Instability and Gait Difficulty; MoCA: Montreal Cognitive Assessment.